Seoul, South Korea

Seung Shin Yu

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2002-2023

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: Seung Shin Yu: Innovator in Gene Therapy

Introduction

Seung Shin Yu is a prominent inventor based in Seoul, South Korea, known for his significant contributions to the field of gene therapy. With a total of six patents to his name, he has made remarkable advancements in the development of innovative therapeutic solutions.

Latest Patents

Among his latest patents is the invention of an adeno-associated virus (AAV) vector that incorporates a hybrid HGF gene. This invention relates to an AAV vector carrying a predetermined hybrid HGF gene sequence, which allows for the efficient delivery of the hybrid HGF gene to a subject at a high delivery yield. Another notable patent is for anti-Sialyl Tn chimeric antigen receptors, which provide improved compositions for adoptive cell therapies targeting cancers that express the glycoepitope STn on TAG-72.

Career Highlights

Seung Shin Yu has worked with notable companies in the biotechnology sector, including Helixmith Co., Ltd and Viromed Limited. His work in these organizations has contributed to the advancement of gene therapy and cancer treatment.

Collaborations

He has collaborated with esteemed colleagues such as Sunyoung Kim and Jong-Mook Kim, further enhancing the impact of his research and innovations.

Conclusion

Seung Shin Yu's contributions to gene therapy and his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…